Risk of malignancies in patients with insulin-treated diabetes mellitus. Results of a population-based trial with 10-year follow-up (JEVIN)

European Journal of Medical Research

Volumn 10, Issue 8, 2005, Pages 339-344

  Schiel, Ralf ^a,b   Muller U A ^b   Braun, A ^b   Stein, G ^b   Kath, R ^c  

^a Inselklinik Heringsdorf GmbH   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c Philippusstift   (Germany)

Author keywords

Carcinoma; Colon cancer; Diabetes mellitus; HbA1c; Insulin therapy; Malignancy; Rectum cancer

Indexed keywords

ANTINEOPLASTIC AGENT; INSULIN;

ADOLESCENT; ADULT; ARTICLE; BREAST CARCINOMA; CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CLINICAL TRIAL; COHORT ANALYSIS; COLON CANCER; COLON CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES CONTROL; DIABETES MELLITUS; DISEASE DURATION; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; GENITAL TRACT CANCER; GERMANY; HEALTH SURVEY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY CARCINOMA; LONG TERM CARE; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RECTUM CANCER; RECTUM CARCINOMA; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GERMANY; HUMANS; INCIDENCE; INSULIN; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES;

EID: 24144441754     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Becker N, Wahrendorf J (eds) (1997) Atlas of cancer mortality in the Federal Republic of Germany 1981-1990. Springer, Berlin, Germany
2. Bornfeldt KE, Gidlöf RA, Wasteson A, Lake M, Skottner A, Arnqvist HJ (1991) Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities. Diabetologia 34: 307-313
3. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159: 1160-1167
4. Davies MJ, Metcalfe J, Gray IP, Day JL, Hales CN (1993a) Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type 2 diabetes mellitus. Diabetic Med 10: 305-312
5. Davies MJ, Rayman G, Gray IP, Day JL, Hales CN (1993b) Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabetic Med 10: 313-320
6. De Meyts P (1994) The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling. Diabetologia 37: S135-S148
7. De Meyts P, Christoffersen CT, Ursö B, Ish-Shalom D, Sacerdoti-Sierra N, Drejer K, Schäffer L, Shymko RM, Naor D (1993) Insulin's potency as a mitogen is determined by the half-life of the insulin-receptor complex. (Abstract) Exp Clin Endocrinol 101: 22-23
8. Del Guidice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwin PJ (1998) Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47: 111-120
9. Del Prato S, Bruttomesse D (1996) Clinical aspects of beta-cell dysfunction in NIDDM. Diabetes News 17: 1-8
10. Early treatment diabetic retinopathy study group (1991) Ophthalmology 98, Suppl 5
11. Folsom AR, Anderson KE, Sweeney C, Jacobs DR (2004) Diabetes as a risk factor for death following endometrial cancer. Gynecol Oncol 94: 740-745
12. Green A, Jensen OM (1985) Frequency of cancer among insulin-treated diabetic patients in Denmark. Diabetologia 28: 128-130
13. Gullo L (1999) Diabetes and the risk of pancreatic cancer. Ann Oncol 10: S79-S81
14. Hofmann C, Goldfine ID, Whittaker J (1989) The metabolic and mitogenic effects of both insulin and insulin-like growth factor are enhanced by transfection of insulin receptors into NIH3T3 fibroblasts. J Biol Chem 15: 8606-8611
15. Huo TI, Wu JC, Lui WY, Huang YH, Lee PC, Chiang JH, Chang FY, Lee SD (2004) Differential mechanism and prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma undergoing surgical and nonsurgical treatment. Am J Gastroenterol 99: 1479-1487
16. Janeczko D, Kopezynski J, Czyzyk A, Janeczko-Sosnowska E, Tuszynska A, Lewadowski Z (1998) Mortality of diabetic patients in Warsaw - 22 year prospective observation (1973/74-1995). II. Mortality of patients with type I diabetes (insulin-dependent). Pol Arch Med Wewn 100: 165-171
17. Kath R, Rodeck U, Parmiter A, Jamborsic J, Herlyn M (1990) Growth factor independence in vitro of primary melanoma cells from advanced but not early or intermediate lesions. Cancer Ther Control 1: 179-191
18. Kath R, Schiel R, Müller UA, Höffken K (2000) Malignancies in patients with insulin-treated diabetes mellitus. J Cancer Res Clin Oncol 126: 412-417
19. Kopp S, Tanneberger S, Möhner M, Kieser R (1990) Diabetes and breast cancer risk. Int J Cancer 46: 751-752
20. Lindblad P, Chow WH, Chan J, Bergstrom A, Wolk A, Gridley G, McLaughlin JK, Nyren O, Adami HO (1999) The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia 42: 107-112
21. Liu Z, Koo L (2001) Relative risk for colorectal cancer in patients with typ diabetes mellitus. (Abstract) Diabetes 50 : A220
22. Mendelsohn J (1995) Prinzipien der Neoplasie. In: Schmailzl K (ed). Harrisons Innere Medizin, Vol 2. Blackwell Science, Berlin, Germany, pp 2123-2137
23. Müller UA, Ross IS, Klinger H, Geisenheiner S, Chantelau EA (1993) Quality of centralized diabetes care: a population-based study in the German Democratic Republic 1989-1990. Acta Diabetol 30: 166-172
24. Nerlich AG, Hagedorn HG, Boheim M, Schleicher ED (1998) Patients with diabetes-induced microangiopathy show a reduced frequency of carcinomas. In Vivo 12: 667-670
25. O'Mara BA, Byers T, Schoenfeld E (1985) Diabetes mellitus and cancer risk: A multisite case-control-study. J Chronic Dis 38: 435-441
26. Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Järvinen H, Evron W, Dailey G, Gerich J (1995) Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with first-degree NIDDM relative. JAMA 273: 1855-1861
27. Polonsky KS, Given BD, Hirsch LJ, Tillh H, Shapiro ET, Beebe C, Frank BH, Galloway JA, Van Cauter E (1988) Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med 318: 1231-1239
28. Reaven GM (1995) Pathophysiology of insulin resistance in human disease. Physiol Rev 75: 473-486
29. Rodeck U, Herlyn M, Menssen HD, Furlanetto RW, Koprowski H (1987) Metastatic but not primary melanoma cells in vitro independently from exogenous growth factors. Int J Cancer 40: 687-690
30. Rosskamp RH, Park G (1999) Long-acting insulin analogs. Diab Care 22: B109-B113
31. Schiel R, Voigt U, Ross IS, Braun A, Rillig A, Hunger-Dathe W, Stein G, Müller UA (2005) Structured diabetes therapy and education improves the outcome of patients with insulin treated diabetes mellitus. The 10 year follow-up of a prospective, population-based survey on the quality of diabetes care [The JEVIN trial]. Exp Clin Endocrinol Diabetes, in press
32. Schiel R, Braun A, Rillig A, Voigt U, Ross IS, Müller UA (2001) Improvement of the quality of diabetes care - JEVIN, a population-based survey with 10-years-follow-up: 1989/1990 - 1999/2000. (Abstract) Diabetologia 44: A247
33. Schiel R, Franke S, Appel T, Voigt U, Ross IS, Kientsch-Engel R, Stein G, Müller UA (2003) Improvement in quality of diabetes control and concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus studied over a period of 10 years (JEVIN). J Diab Complications 17: 90-97
34. Schiel R, Müller UA, Sprott H, Schmelzer A, Mertes B, Hunger-Dathe W, Ross IS (1997) The JEVIN-trial: A population-based survey on the quality of diabetes care in Germany - 1994/95 compared to 1989/90. Diabetologia 40: 1350-1357
35. Sellers TA, Anderson KE, Olsen JE, Folsom AR (1998) Family histories of diabetes mellitus and breast cancer and the incidence of postmenopausal breast cancer. Epidemiology 9: 102-105
36. Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vechia C (1997) Selected medical conditions and risk of breast cancer. Br J Cancer 75: 1699-1703
37. The expert committee on the diagnosis and classification of diabetes mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diab Care 20: 1183-1197
38. Unterberger P, Sinop A, Noder W, Berger MR, Fink M, Edler L, Schmähl D, Erhart H (1990) Diabetes mellitus und Mammakarzinom. Eine retrospektive Verlaufsstudie. Onkologie 13: 17-20
39. Widerhoff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, Borch-Johnsen K, Olsen JH (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89: 1360-1365
40. Yang YX, Hennessy S, Lewis JD (2004) Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 127: 1044-1050
41. Yki-Järvinen H (1995) Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia 38: 1378-1388
42. Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonksen PH (1993) A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36: 150-154